SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
PCE(x) | 31.86 | 21.27 | 39.55 | 32.85 | 13.54 |
What is the latest Price to Cash Earnings (PCE) ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Price to Cash Earnings (PCE) |
---|---|
Mar2024 | 31.86 |
Mar2023 | 21.27 |
Mar2022 | 39.55 |
Mar2021 | 32.85 |
Mar2020 | 13.54 |
How is Price to Cash Earnings (PCE) of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Price to Cash Earnings (PCE) | % Change | |
---|---|---|---|
Mar2024 | 31.86 | 49.79 | |
Mar2023 | 21.27 | -46.22 | |
Mar2022 | 39.55 | 20.40 | |
Mar2021 | 32.85 | 142.61 | |
Mar2020 | 13.54 | - |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹443,018.7 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics | |
MANKIND PHARMA | ₹97,396.6 Cr | -2.7% | 6.6% | 33.4% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% |
4.7% |
60.2% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses